163 related articles for article (PubMed ID: 18227614)
1. Ciprofloxacin breakpoints in enteric fever--time to revise our susceptibility criteria.
Rodrigues C; Kumar NJ; Lalwani J; Mehta A
Indian J Med Microbiol; 2008; 26(1):91. PubMed ID: 18227614
[No Abstract] [Full Text] [Related]
2. A need to revise ciprofloxacin breakpoints for Salmonella in human beings.
Gupta V; Kaur J
Int J Infect Dis; 2008 Nov; 12(6):e143-4. PubMed ID: 18514007
[No Abstract] [Full Text] [Related]
3. Alternatives to ciprofloxacin use for enteric Fever, United kingdom.
Threlfall EJ; de Pinna E; Day M; Lawrence J; Jones J
Emerg Infect Dis; 2008 May; 14(5):860-1. PubMed ID: 18439388
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin breakpoints in enteric fever: time to revise our susceptibility criteria.
Gupta LK; Randhawa VS
Indian J Med Microbiol; 2008; 26(4):406. PubMed ID: 18974511
[No Abstract] [Full Text] [Related]
7. Ciprofloxacin breakpoints in enteric fever: time to revise our susceptibility criteria.
Rodrigues C; Kumar NJ; Lalwani J; Mehta A
Indian J Med Microbiol; 2009; 27(3):276. PubMed ID: 19584518
[No Abstract] [Full Text] [Related]
8. [Typhoid and paratyphoid fever].
Trawinski H; Wendt S; Lippmann N; Heinitz S; von Braun A; Lübbert C
Z Gastroenterol; 2020 Feb; 58(2):160-170. PubMed ID: 32050286
[TBL] [Abstract][Full Text] [Related]
9. Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa.
Bhattacharya SS; Das U; Choudhury BK
Indian J Med Res; 2011 Apr; 133(4):431-3. PubMed ID: 21537098
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella.
Alam MN; Haq SA; Das KK; Baral PK; Mazid MN; Siddique RU; Rahman KM; Hasan Z; Khan MA; Dutta P
Am J Trop Med Hyg; 1995 Sep; 53(3):306-11. PubMed ID: 7573719
[TBL] [Abstract][Full Text] [Related]
11. Antibiogram of Salmonella typhi and Salmonella paratyphi A in a tertiary care hospital in 2012.
Venkatesh BM; Joshi S; Adhikary R; Bhaskar BH
Indian J Pathol Microbiol; 2013; 56(4):484-5. PubMed ID: 24441263
[No Abstract] [Full Text] [Related]
12. The management of antimicrobial-resistant enteric fever.
Parry CM; Basnyat B; Crump JA
Expert Rev Anti Infect Ther; 2013 Dec; 11(12):1259-61. PubMed ID: 24215240
[No Abstract] [Full Text] [Related]
13. High level ciprofloxacin resistance in Salmonella enterica isolated from blood.
Raveendran R; Wattal C; Sharma A; Oberoi JK; Prasad KJ; Datta S
Indian J Med Microbiol; 2008; 26(1):50-3. PubMed ID: 18227598
[TBL] [Abstract][Full Text] [Related]
14. Treatment with ciprofloxacin in children with typhoid fever.
Thomsen LL; Paerregaard A
Scand J Infect Dis; 1998; 30(4):355-7. PubMed ID: 9817514
[TBL] [Abstract][Full Text] [Related]
15. Emerging Salmonella Paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of salmonella in Shimla.
Verma S; Thakur S; Kanga A; Singh G; Gupta P
Indian J Med Microbiol; 2010; 28(1):51-3. PubMed ID: 20061765
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
[TBL] [Abstract][Full Text] [Related]
17. Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.
Morita M; Ito K; Hirose K; Takahashi H; Shimuta K; Terajima J; Ohnishi M; Harada M; Matsuzaki M; Watanabe H; Izumiya H
Microbiol Immunol; 2006; 50(9):707-11. PubMed ID: 16985292
[TBL] [Abstract][Full Text] [Related]
18. [Typhoid and paratyphoid fever].
Sagara H
Nihon Rinsho; 2003 Feb; 61 Suppl 2():395-400. PubMed ID: 12722250
[No Abstract] [Full Text] [Related]
19. Multi drug resistant Salmonella typhi in Ludhiana (Punjab).
Gupta B; Kumar R; Khurana S
Indian J Pathol Microbiol; 1993 Jan; 36(1):5-7. PubMed ID: 8354556
[TBL] [Abstract][Full Text] [Related]
20. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins.
Capoor MR; Nair D; Deb M; Aggarwal P
J Med Microbiol; 2007 Aug; 56(Pt 8):1131-1132. PubMed ID: 17644728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
